THE MOSS REPORTS Newsletter (09/05/04)

[Guest guest]

> 5 Sep 2004 21:50:11 -0000

> " Cancer Decisions "

> <

 

> THE MOSS REPORTS Newsletter (09/05/04)

>

----------------------

> Ralph W. Moss, Ph.D. Weekly CancerDecisions.com

> Newsletter #148 09/05/04

>

----------------------

>

> A NOTE FROM THE STAFF AT CANCER DECISIONS

>

>

> The Journal of Integrative Cancer Therapy is a

> peer-reviewed, PubMed-listed medical journal. While

> normally the journal only releases the full text of

> its articles to rs, two recent articles by

> Dr. Ralph Moss will be available in full online from

> the journal's publisher, Sage Publications, until

> the end of October. You can access these articles

> either by going to the publisher's website,

> www.sagepub.com and typing in 'Moss, RW' in the

> search engine, or by clicking or going to:

>

http://online.sagepub.com/cgi/searchresults?fulltext= & author1=Moss%2C+R & src=hw & h\

its=10 & hitsbrief=25 & resourcetype=1 & andorexactfulltext=and

>

>

> CANCER CONTROL SOCIETY AWARD

>

>

> I am in Los Angeles this week at the 32nd annual

> convention of the Cancer Control Society (CCS),

> where I will receive the Society's Humanitarian

> Award. The meeting is held each year over Labor Day

> weekend (this year September 4-6) at the Sheraton

> Universal Hotel, opposite Universal Studios in

> Hollywood. It brings together physicians,

> researchers, activists and cancer patients from all

> over the world. Approximately 1,200 participants

> will gather to discuss the latest developments in

> the field of complementary and alternative medicine

> (CAM).

>

> For over three decades, under the leadership of Ms.

> Lorraine Rosenthal, the CCS has been a source of

> hard-to-find information on alternative treatments.

> Its annual convention has functioned as a showcase

> for many new ideas in the CAM approach to cancer. I

> have spoken at the CCS meetings several times since

> the 1970s.

>

> It is a particular honor for me to receive the CCS

> Humanitarian Award. Previous recipients have

> included such notables as Stanislaw R. Burzynski,

> MD, PhD, Prof. Samuel S. Epstein, MD, Josef M.

> Issels, MD, and O. Carl Simonton, MD.

>

>

> The Award Citation reads as follows:

>

>

> " For over 30 years, you have fought for the fair

> testing of Complementary and Alternative cancer

> therapies. In the 1970s, you lost your position at

> the Memorial Sloan-Kettering Cancer Center, when you

> exposed the cover-up of positive experiments with

> Laetrile (amygdalin).

>

> " Your 11 books, such as " The Cancer Industry, "

> " Herbs Against Cancer, " and " Questioning

> Chemotherapy " are beacons of light for thousands of

> cancer patients and practitioners.

>

> " You were instrumental in helping to create the

> National Center for Complementary and Alternative

> Medicine at the National Institutes of Health.

> Because of your efforts, these therapies have now

> become a respected branch of medicine.

>

> " You have tirelessly advised and counseled thousands

> of cancer patients. For the past 10 years you have

> researched and written The Moss Reports, which

> inform patients of their options in over 200 types

> of cancers. Your weekly Moss Report newsletter has

> gone out to tens of thousands of cancer patients and

> families.

>

> " You were among the first to grasp the potential of

> the Internet and in 1997 you wrote the book

> " Alternative Medicine Online. " Your

> cancerdecisions.com website is now the #1 rated site

> for the topic " alternative cancer treatments " in

>

>

> " You are the conscience of the cancer community and

> we hereby acknowledge your achievements as an

> investigative journalist, a passionate voice for

> patients' rights and a crusader for the truth! "

>

> This is the third honor I have received in as many

> years from leading organizations in the field of

> CAM. (The other two were from the National

> Foundation for Alternative Medicine in 2002 and the

> American College for Advancement in Medicine in

> 2003.) On a personal level it is enormously

> gratifying to receive such honors, however, I see

> them also as an endorsement of the particular

> approach to alternative treatments that I have taken

> over the years.

>

> Back in 1977, I wrote the following about the

> Laetrile/amygdalin controversy: " Our interest in

> Laetrile has always been to have it adequately

> tested and to have all those research results

> released….The focus of the Laetrile movement should

> be to mobilize large numbers of people to demand the

> truth from the scientific establishment about this

> agent, and all issues related to cancer. "

>

> Consistently, over the years, I have put my emphasis

> on fostering the fair scientific evaluation of the

> various methods that are used in the treatment of

> cancer, from surgery to the far-out alternative

> treatments coming from outside the mainstream. A

> belief in the value of good science is the

> underlying principle of all that I write and do. I

> seek the cooperation of all likeminded people who

> want to see CAM subjected to intensive but

> even-handed scrutiny.

>

>

> DEPARTMENT OF CORRECTIONS

>

>

> In last week's newsletter I discussed the

> increasingly popular and widely promoted Chinese

> remedy known as Tian Xian. (The spelling of this

> name varies widely since it is a transliteration

> from Chinese.)

>

> In my discussion, I pointed out that there were no

> scientific studies of Tian Xian available in the

> National Library of Medicine's database, PubMed.

> This is incorrect. What I meant to say was that

> there had been no studies of the use of Tian Xian in

> the treatment or prevention of cancer. There is in

> fact one scientific study of Tian Xian available in

> the database, concerning the possible use of the

> compound in the management of aphthous ulcers

> (canker sores) in the mouth. The reference for this

> study appears below:

>

> Sun A, Chia JS, Wang WB, Chiang CP. Immunomodulating

> effects of " tien-hsien liquid " on peripheral blood

> mononuclear cells and T-lymphocytes from patients

> with recurrent aphthous ulcerations. Am J Chin Med.

> 2004;32(2):221-34.

>

>

>

> --Ralph W. Moss, PhD

>

> ---------------

> IMPORTANT DISCLAIMER

>

> The news and other items in this newsletter are

> intended for informational purposes only. Nothing in

> this newsletter is intended to be a substitute for

> professional medical advice.

>

> --------------

>

> IMPORTANT NOTICE:

>

> Please do not REPLY to this letter. All replies to

> this email address are automatically deleted by the

> server and your question or concern will not be

> seen. If you have questions or concerns, use our

> form at

> http://www.cancerdecisions.com/contact.html

> Thank you.

>

> MEMBERS may also write to:

> mossreports

> Thank you.

>

>

> To SUBSCRIBE TO OUR FREE NEWSLETTER: Please go to

> http://cancerdecisions.com/list/optin.php?form_id=8

> and follow the instructions to be automatically

> added to this list.

> Thank you.

>

> =====